Wolfgang Treiber

Learn More
BACKGROUND Correction of low hemoglobin (Hb) levels is associated with improved survival and greater quality of life in dialysis patients, but frequent administration of erythropoiesis stimulating agent (ESA) therapy is unsatisfactory for peritoneal dialysis patients. OBJECTIVE The objective of this study was to assess Hb stability in an unselected(More)
  • 1